HTGF and VP Venture Partners back CollimateHealth's €6M bet that hair-thin radiation beams can out-compete chemotherapy — TFN

Munich deep-tech startup CollimateHealth has raised €6M to develop microbeam radiation therapy, a cancer treatment using ultra-thin beams to target tumours and activate the immune system.

Raccontata datechfundingnews.com